Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Insiders continue to Buy 750 k in warrants May 14 2022

<< Previous

Bullboard Posts

Next >>

Comment by NotinKansason May 25, 2022 2:23am

260 Views

Post# 34705501

RE:RE:RE:RE:RE:RE:RE:Insiders continue to Buy 750 k in warrants May 14 2022

To me, Rodger and Kristina’s willingness to invest another $225k in the company at this point signals not only that they feel confident about the company’s future, but also that they do not see another low ball placing coming. Otherwise, they surely would have kept their powder dry, I’d think. It gives me considerable peace of mind.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market